29th June 2021
Drug Discovery News
Five Arrows invests in Sygnature Discovery
16th June 2021
Drug Discovery News
Sygnature Discovery expands into early CMC development
27th April 2021
Drug Discovery News
Sygnature Discovery expands US presence with Bay Area office
18th February 2021
Drug Discovery News
Sygnature Creates Second Integrated Drug Discovery Site at Alderley Park
21st January 2021
Computational Sciences Drug Discovery News
Sygnature Discovery Adopts OpenEye’s Orion™ Platform to Strengthen Molecular Design Services
11th June 2020
Drug Discovery News
Sygnature assists New York Medical College in the fight against Covid-19
29th May 2020
Bioscience Drug Discovery News
Sygnature Discovery expands SPR capacity
4th November 2019
Bioscience Drug Discovery News
Sygnature Discovery invests in high-throughput screening capability
17th April 2019
Computational Sciences Drug Discovery News
Sygnature Discovery announces collaboration with software firm SilcsBio
6th February 2019
Drug Discovery News
Pathios Therapeutics and Sygnature Discovery sign strategic partnership
8th November 2018
Drug Discovery News
Sygnature Discovery in multi-target drug discovery deal with Sitryx Therapeutics
15th August 2018
DMPK Drug Discovery News
Sygnature Discovery announces expansion at Alderley Park